Effectiveness, Safety, and Patient-Reported Outcomes (PROs) in Patients With Hereditary Angioedema (HAE) From the United States and Canada Treated With Lanadelumab: 24-Month Data From the EMPOWER Study

Subjects

Subjects :

Immunology
Immunology and Allergy

Details

ISSN :

00916749

Volume :

151

Database :

OpenAIRE

Journal :

Journal of Allergy and Clinical Immunology

Accession number :

edsair.doi...........66985f3ecd2f9c363f5cf6e2a86166dd

Full Text :

https://doi.org/10.1016/j.jaci.2022.12.413